Studies of Dengue pathogenesis and vaccines in Vietnam for improved case management and primary prevention .
In plain English
AI plain-English summaryDengue virus infections send hundreds of thousands of children in Vietnam to hospital each year, and a small but dangerous fraction develop dengue shock syndrome—a sudden, life-threatening drop in blood pressure. This research tackles two linked problems: doctors cannot reliably predict which patients will deteriorate, and there is no licensed dengue vaccine for use in Vietnam. The researcher will analyse blood samples from patients early in their illness to find viral and immune markers that signal impending shock, then build simple classification tools that frontline clinicians can use to triage patients. Separately, a long-term birth cohort study will track which immune responses protect children from severe disease, while a clinical trial will test a live-attenuated tetravalent vaccine in Vietnamese volunteers. If successful, the work could produce cheap, rapid point-of-care tests for hospital triage, replace the current WHO dengue classification with evidence-based algorithms, and generate the safety and immunogenicity data needed to justify a larger vaccine efficacy trial. Together, these changes would shift dengue management from reactive emergency care toward early intervention and primary prevention.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Senior Research Fellowship BasicPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know